Navigation Links
Medicare Spending Caps Cause Seniors to Stop Meds
Date:9/11/2007

In many cases, patients never take these important medications again, study finds

TUESDAY, Sept. 11 (HealthDay News) -- Some American seniors stop taking medications for chronic health problems such as high blood pressure and diabetes when they exceed spending limits in their Medicare prescription drug plans, new research shows.

The study, by the nonprofit research organization the RAND Corporation, also found that many of those seniors do not resume taking their prescription drugs when their drug benefits kick in again at the start of a new health plan year.

The RAND team analyzed prescription drug use from 2003 to 2005 among 60,000 seniors enrolled in a health plan offered by a large national employer. The seniors were enrolled in one of three drug plans: one with a spending limit of $1,000; one with a spending limit of $2,500; and one with no spending limit. In each of the plans, enrollees had to pay a portion of their drug purchases.

The study looked at the use of drugs to treat high blood pressure, cardiac problems, diabetes, ulcers, depression, and prescription pain medications that have over-the-counter substitutes.

Reporting in the Sept./Oct. issue of the journal Health Affairs, the researchers found that 6 percent to 13 percent of seniors enrolled in drug plans with spending caps reached their spending limit in each of the years of the study. Of those who reached their spending limits, about half went without drug benefits for more than 90 days.

Seniors in capped plans who spent the most on drugs were more likely to discontinue their use of medications than those in plans with no cap.

Discontinuation of drugs varied from 15 percent for anti-cholesterol medications to 28 percent for cardiac drugs, the study found.

"Prescription use falls significantly as patients reach their benefit caps," lead author Geoffrey Joyce, a senior economist at RAND, said in a prepa
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Medicare Drug Deadline not to be extended
2. House heads for Medicare drug vote
3. New Medicare Plan - Mixed Reaction among Pharmacists.
4. Medicare Data would help in Drug Validation
5. Medicare Queries Expected To Increase Over Time
6. Medicare to cover services provided by rural health care personnels.
7. Cancer test expenses taken up by Medicare
8. Nurse Practitioners Are Not Recognized By Medicare
9. Medicare Drug Plan Is Not Working in The US
10. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
11. Rising Medicare costs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...lar cancer who were treated with cisplatin-based c...g neurological side effects and Raynaud-like pheno...apy, according to a new study published online Nov...stitute . , Marianne Brydy, M.D., of the Departm... Bergen, Norway, and colleagues conducted a cross-...
(Date:11/25/2009)...grew out of a collaboration between UCLA engineers...e nearly 10 million Americans who suffer from peri...dening of the arteries, peripheral arterial diseas...h narrowed arteries reduce blood flow to the limbs...lar disease, heart attack and stroke, and its prog...
(Date:11/25/2009)...oo short to draw definite conclusions, experts say...s) -- In diabetic patients with blocked coronary a...omes at one year whether patients undergo bypass s...rchers report. , Bypass surgery has been the st...ry artery disease. However, less invasive approach...
(Date:11/25/2009)...tion and treatment clinics to resume Monday, Nov. ...vember 25, 2009 -- Centegra Health System is conti...e shots at four Centegra Primary Care (CPC) vaccin...s arrived. The clinics are at CPC sites in Huntley...open as follows: ,   From 4:30 to 7:30...
(Date:11/25/2009)...logical symptoms, study finds , , WEDNE...e effects are among the potential problems faced b...e treated with cisplatin-based chemotherapy, a new...rwegian men treated for unilateral testicular canc...-up survey conducted from 1998 to 2002. , The r...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... Fair 2008 to Focus on Wellness,and Safety, NEW Y...he Montefiore Medical Center:, WHAT:, For famili...mes for,this year,s Keeping Kids Healthy Children,...Hospital at Montefiore,Mosholu-Montefiore Communit...
...,Biomedical Excellence for Safer Transfusion (BEST...garding the scientific validity and medical,implic... that transfusion,of older units of Red Blood Cell...isory Committee on Blood Safety and,Availability (...
...y Jubilant, TORONTO, May 27 /PRNewswire-FirstCall...AQ: DRAX ) announced today that it has obtained a...nection with the previously,announced proposed sta..."Jubilant") for US$6.00 per common share. The,arra...
...in arteries rather than amount , , TUESDA...of a person,s heart attack risk can be achieved us...ount not only the amount, but also the distributio...cularly important in estimating a patient,s potent...
... any increased risk, researchers find , ,...he patients with a history of heart disease are un...on,t see themselves being at increased risk for on...isk of having a heart attack or dying, compared wi...
...um GmbH have today signed a contract worth 263 mil... Earth Explorer mission of ESAs Living Planet Prog...sible for the satellites design, development and i... of Earth Observation, Evert Dudok, CEO of Astrium...
Other Medicine News:Health News:International Research Organization Responds to Recent Studies Purporting to Show That Transfusion of Older Red Blood Cells Leads to Greater Risk 2Health News:International Research Organization Responds to Recent Studies Purporting to Show That Transfusion of Older Red Blood Cells Leads to Greater Risk 3Health News:DRAXIS Obtains Final Order for Proposed Arrangement 2Health News:DRAXIS Obtains Final Order for Proposed Arrangement 3Health News:DRAXIS Obtains Final Order for Proposed Arrangement 4Health News:New Calcium Measure Better Predictor of Heart Risks 2Health News:Many With Heart Disease Don't Know Signs of Heart Attack 2Health News:Many With Heart Disease Don't Know Signs of Heart Attack 3Health News:EarthCARE satellite contract signed 2
(Date:11/25/2009)...YORK,Nov.25/PRNewswire/--Reportlinker.comannounces...gue: ,, PainManagement-GlobalTrends ,, ...nt---Global-Trends.html ,, Widespreadavailabil...,andtheadventofnewdrugshaveacceleratedthepaceofgro...eimbursementstructurecontinuetoshapedemandforservi...
(Date:11/25/2009)...FT,TheNetherlandsandJOHANNESBURG,November25/PRNews...yxisDiscoveryannouncedtoday,thattheyhavesignedacol...ervices. , Pyxis,sworldclasscomputationalchem...hemba,sservicedivisiontoprovidemedicinaland,synthe...s,internationalclientnetwork.iThembaPharmaceutica...
(Date:11/25/2009)...NTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCentry...omtheCompany,sPROTECT-1(theProspectiveRandomizedOr...t-EN(TM)(CCX282-B)inpatientswithmoderate-to-severe...orablesafetyandtolerabilityprofile.Thestudydemonst...easeseverityasdefinedasa70-pointdecreaseintheCrohn...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Greenway Medical Technologies EHR Solution PrimeSuite Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Science 53493 1Greenway Medical Technologies EHR Solution PrimeSuite Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Science 53493 2Greenway Medical Technologies EHR Solution PrimeSuite Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Science 53493 3Greenway Medical Technologies EHR Solution PrimeSuite Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Science 53493 4Researchers effectively treat tumors with use of nanotubes 53492 1Researchers effectively treat tumors with use of nanotubes 53492 2Researchers effectively treat tumors with use of nanotubes 53492 3Unlocking the key to human fertility 53490 1Unlocking the key to human fertility 53490 2Unlocking the key to human fertility 53490 3
Ovation BioNatural Pipette, one-stroke, fixed volume, 200L
Finnpipette Fixed Volume, 200ul
Pipetman F100
Eppendorf Research Series 2100 Fixed-volume Pipette, 100 l
Medicine Products: